Drug
Metreleptin
Metreleptin: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Metreleptin NCT06679270 | Phase 3 | Familial Partial Lipodystrophy |
Latest
No recent events.
Follow Metreleptin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.